# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Giant Cell Arteritis
- **MONDO ID:**  (if available)
- **Category:** Autoimmune

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Giant Cell Arteritis**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2025-12-18T09:54:01.698899

1. stamatis2022pathogenesisofgiant pages 7-9
2. almousawi2019reviewingthepathophysiology pages 1-3
3. samec2023relapseriskand pages 1-3
4. costanzo2024pharmacologicaladvancesin pages 3-5
5. loricera2024effectivenessofjanus pages 1-2
6. eriksson2023clinicalexperienceand pages 1-2
7. oprisbelinski2024currentperspectivesin pages 9-11
8. oprisbelinski2024currentperspectivesin pages 2-3
9. weyand2023immunologyofgiant pages 1-3
10. weyand2023immunologyofgiant pages 19-24
11. tomelleri2024longtermpathophysiologicandb pages 19-22
12. tomelleri2024longtermpathophysiologicand pages 19-22
13. oprisbelinski2024currentperspectivesin pages 8-9
14. Checkpoint 1
15. Checkpoint 3
16. with
17. creating
18. https://doi.org/10.1161/circresaha.122.322128
19. https://doi.org/10.3389/fmed.2022.1058600
20. https://doi.org/10.3390/cells13050430
21. https://doi.org/10.3389/fimmu.2020.587089
22. https://doi.org/10.1001/jamaneurol.2015.2101
23. https://doi.org/10.3390/vaccines12030252;
24. https://doi.org/10.3390/biom14070739
25. https://doi.org/10.3899/jrheum.2022-1214
26. https://doi.org/10.37349/eaa.2024.00054
27. https://doi.org/10.1186/s13075-024-03314-9
28. https://doi.org/10.3389/fimmu.2023.1187584
29. https://doi.org/10.3390/medicina60030400
30. https://doi.org/10.3390/vaccines12030252
31. https://doi.org/10.1161/circresaha.122.322128,
32. https://doi.org/10.3389/fmed.2022.1058600,
33. https://doi.org/10.1007/s40123-019-0171-0,
34. https://doi.org/10.37349/eaa.2024.00054,
35. https://doi.org/10.3390/medicina60030400,
36. https://doi.org/10.3899/jrheum.2022-1214,
37. https://doi.org/10.1186/s13075-024-03314-9,
38. https://doi.org/10.3389/fimmu.2023.1187584,